News & Events
DATE2025.03.17
VIEWS216
The Germany Biotech Industry Exploration Program - Global Expedition to Germany - is designed
to support Korean biotech companies in expanding their global presence
by facilitating in-depth industry insights and strategic networking opportunities in Germany.
This program is organized in collaboration with the KoreaBIO and Midas Pharma,
providing participants with firsthand exposure to Germany’s advanced biotech ecosystem.
It took place from March 12 to 14 across several German cities,
including Ingelheim, Mainz, Ulm, Laupheim, and Munich.
This initiative is part of the Global Mingle program, which aims to assist Korean biotech firms in securing global partnerships,
attracting foreign investments, and advancing their international business development,
this program combined participation in BIO Europe 2025 Spring with an exploratory tour of Germany's biotech industry.
The initiative focused on strengthening the companies' global presence
and fostering collaboration opportunities with major European pharmaceutical and biotech companies.
Participating companies visited the headquarters of leading German companies and biotech clusters,
including Boehringer Ingelheim, Biomindz Biotech Hub, Evonik, Midas Pharma, Schott Pharma,
Rentschler Biopharma, Vetter Pharma, and Biotech Cluster South GER.
They engaged in business development meetings with key industry representatives,
gaining insights into the German biotech ecosystem and exploring potential partnerships.